Handelsinvest Investeringsforvaltning’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,110	Closed	-$183K	–	325
2023 Q4	$183K	Buy	+3,110	New	+$175K	0.07%	313
2021 Q2	–	Sell	-15,000	Closed	-$2.57M	–	129
2021 Q1	$2.57M	Buy	15,000 +2,500	+20%	+$495K	0.31%	104
2020 Q4	$2.75M	Hold	12,500	–	–	0.41%	82
2020 Q3	$2.08M	Buy	+12,500	New	+$1.71M	0.39%	77

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's MRTX Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 3,110 shares — an estimated $183K sold.

Handelsinvest Investeringsforvaltning first reported a position in MRTX in Q3 2020 and held it in 4 quarters. The position peaked at $2.75M in Q4 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Handelsinvest Investeringsforvaltning reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 3,110 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $183K.
Handelsinvest Investeringsforvaltning first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Handelsinvest Investeringsforvaltning's Mirati Therapeutics, Inc. Common Stock position peaked at $2.75M in Q4 2020.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.